Subsequent Events |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Subsequent Events [Abstract] | |
| Subsequent Events |
Note 7 – Subsequent Events
On October 14, 2026, Matt David, M.D., commenced service as Chief Financial Officer and principal financial officer of the Company.
In October 2026, the Company’s Board of Directors adopted an inducement award plan pursuant to which 1.5 million shares of the Company’s common stock were reserved for issuance as equity-based inducement awards to eligible new employees. On October 12, 2026 the Company granted options to purchase 40 thousand shares, having an exercise price of $1.06 per share, vesting over four years and having a grant date fair value of $31 thousand. The Company also granted RSUs for 70 thousand shares, having a grant date fair value of $74 thousand, with 20 thousand units vesting on the first, second and third anniversaries of the grant date and 50 thousand units vesting on the third anniversary of the grant date. On October 14, 2026, the Company granted options to purchase 250 thousand shares, having an exercise price of $0.9746 per share, vesting over four years and having a grant date fair value of $178 thousand. The Company also granted RSUs for 325 thousand shares, having a grant date fair value of $317 thousand, with 125 thousand units vesting on the first, second and third anniversaries of the grant date, 125 thousand units vesting on the third anniversary of the grant date and 75 thousand units vesting on the accomplishment of certain corporate milestones. |